CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sapir Alex See Remarks | Grant or award · Stock option - Right to Buy | +650,000 | 650,000 | ||
| 2025-01-24 | Sapir Alex See Remarks | Grant or award · Stock option - Right to Buy | +582,000 | 582,000 | ||
| 2024-07-03 | Sapir Alex See Remarks | Option exercise | +150,000 | $3.27 | $491K | 193,360 |
| 2024-07-03 | Sapir Alex See Remarks | Option exercise · Stock option - Right to Buy | −150,000 | 2,280,400 | ||
| 2024-03-04 | Sapir Alex See Remarks | Purchase | +43,360 | $11.35 | $492K | 43,360 |
Page 1 of 1 · 5 trades